MIC breakpoints (μg/ml) | ||||||
---|---|---|---|---|---|---|
DIN | EUCAST | |||||
Drug | S | I | R | S | I | R |
Enterobacteriaceae | ||||||
pip./taz. | ≤4 | 8-32 | >32 | ≤8 | 16 | >16 |
cefotaxime | ≤2 | 4-8 | >8 | ≤1 | 2 | >2 |
imipenema | ≤2 | 4 | >4 | ≤2 | 4-8 | >8 |
ciprofloxacin | ≤1 | 2 | >2 | ≤0.5 | 1 | >1 |
gentamicin | ≤1 | 2-4 | >4 | ≤2 | 4 | >4 |
Pseudomonas aeruginosa | ||||||
piperacillin | ≤4 | 8-32 | >32 | ≤16 | ─ | >16 |
ceftazidime | ≤4 | 8-16 | >16 | ≤8 | ─ | >8 |
imipenem | ≤2 | 4 | >4 | ≤4 | 8 | >8 |
meropenem | ≤2 | 4-8 | >8 | ≤2 | 4-8 | >8 |
ciprofloxacin | ≤1 | 2 | >2 | ≤0.5 | 1 | >1 |
gentamicin | ≤1 | 2-4 | >4 | ≤4 | ─ | >4 |
Stenotrophomonas maltophilia | ||||||
trim./sulfam. | ≤16 | 32-64 | >64 | ≤4 | ─ | >4 |
Acinetobacter baumanii | ||||||
imipenem | ≤2 | 4 | >4 | ≤2 | 4-8 | >8 |
meropenem | ≤2 | 4-8 | >8 | ≤2 | 4-8 | >8 |
ciprofloxacin | ≤1 | 2 | >2 | ≤1 | ─ | >1 |
gentamicin | ≤1 | 2-4 | >4 | ≤4 | ─ | >4 |
Enterococcus spp. | ||||||
ampicillin | ≤2 | 4-8 | >8 | ≤4 | 8 | >8 |
vancomycin | ≤4 | 8 | >8 | ≤4 | ─ | >4 |
teicoplanin | ─ | ─ | ─ | ≤2 | ─ | >2 |
linezolid | ─ | ─ | ─ | ≤4 | ─ | >4 |
Staphylococcus spp. | ||||||
oxacillinb | ≤1 | ─ | >1 | ≤2 | ─ | >2 |
oxacillinc | ≤1 | ─ | >1 | ≤0.25 | ─ | >0.25 |
vancomycinb | ≤4 | 8 | >8 | ≤2 | ─ | >2 |
vancomycinc | ≤4 | 8 | >8 | ≤4 | ─ | >4 |
teicoplaninb | ─ | ─ | ─ | ≤2 | ─ | >2 |
teicoplaninc | ─ | ─ | ─ | ≤4 | ─ | >4 |
linezolid | ─ | ─ | ─ | ≤4 | ─ | >4 |
rifampicin | ─ | ─ | ─ | ≤0.06 | ─ | >0.5 |
clindamycin | ≤1 | 2-4 | >4 | ≤0.25 | 0.5 | >0.5 |